Elevation of prostatic markers following cardiogenic shock
β Scribed by Maria Koreny; Jeanette Koller-Strametz; Alexander Geppert; Georg Delle Karth; Gottfried Heinz; Gerald Maurer; Peter Siostrzonek
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 26 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Numerous ectopic hormones and markers have been described in small cell carcinoma of the lung as well as in extrapulmonary small cell carcinomas. The authors report a case of a patient with metastatic small cell carcinoma of unknown primary who had very high prostatic acid phosphatase (PAP) and pros
A model of prostate cancer progression based on the expression pattern of informative genes in the human prostate cancer xenograft LuCaP 23.1 is presented. Apparently, there are at least 2 tumor cell populations of LuCaP 23.1, representing 2 different phenotypes. One is NSE (neuron-specific enolase)
Neuroendocrine (NE) differentiation of prostatic adenocarcinomas has received increasing attention in recent years as a result of possible implications on prognosis and therapy. The incidence of NE cells in tumors has been reported from 10% up to 100%. Several studies have shown chromogranin A (CgA)
## Abstract Fiftyβnine patients with stage D carcinoma of the prostate under different modalities of treatment were studied for creatine phosphokinase isoenzyme BB (CKβBB) and prostatic acid phosphatase (PAP) levels in serum by radioimmunoassay (RIA) technique, in order to study the possible use of